Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant EraÁngel Serrano‐Aroca, Adam Brufsky|ACS Nano|2021Cited by 179
Bone-Related Complications and Quality of Life in Advanced Breast Cancer: Results from a Randomized Phase III Trial of Denosumab versus Zoledronic AcidMiguel Martín, Ada Braun, Richard H. Bell et al.|Clinical Cancer Research|2012Cited by 145
First-Line Camizestrant for Emerging <i>ESR1</i> -Mutated Advanced Breast CancerFrançois‐Clément Bidard, Nicholas C. Turner, L. Moreau et al.|New England Journal of Medicine|2025Cited by 106
Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancerGiulia Viale, Victoria de Giorgio‐Miller, Mark Basik et al.|ESMO Open|2023Cited by 76
Association of early menarche with breast tumor molecular features and recurrenceAlexandra R. Harris, A. Heather Eliassen, Tengteng Wang et al.|Breast Cancer Research|2024Cited by 19